Lineage Cell Therapeutics
LCTX
#8147
Rank
S$0.23 B
Marketcap
$1.19
Share price
-3.07%
Change (1 day)
-12.63%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -S$34.51 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$6.18 Million. In 2023 the company made an earning of -S$33.28 Million a decrease over its 2022 earnings that were of -S$30.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$34.51 Million3.7%
2023 -S$33.28 Million9.83%
2022 -S$30.3 Million-54.24%
2021 -S$66.21 Million86.07%
2020 -S$35.59 Million-31.97%
2019 -S$52.31 Million-5.42%
2018 -S$55.31 Million1.1%
2017 -S$54.7 Million-31.06%
2016 -S$79.34 Million-10.38%
2015 -S$88.54 Million29.69%
2014 -S$68.27 Million31.68%
2013 -S$51.85 Million
2011 -S$25.16 Million89.78%
2010 -S$13.26 Million206.06%
2009 -S$4.34 Million-0.58%
2008 -S$4.36 Million164.89%
2007 -S$1.65 Million-30.22%
2006 -S$2.36 Million
2002 -S$2.74 Million-41.04%
2001 -S$4.65 Million-32.04%
2000 -S$6.84 Million-11.85%
1999 -S$7.75 Million
1997 -S$4.98 Million12.12%
1996 -S$4.44 Million106.25%
1995 -S$2.16 Million-11.11%
1994 -S$2.43 Million50%
1993 -S$1.62 Million20%
1992 -S$1.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.17 Billion 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA